Steve Hoffman Sells 41,250 Shares of Tyme Technologies, Inc. (NASDAQ:TYME) Stock

Tyme Technologies, Inc. (NASDAQ:TYME) insider Steve Hoffman sold 41,250 shares of the company’s stock in a transaction on Tuesday, June 8th. The stock was sold at an average price of $1.57, for a total transaction of $64,762.50. Following the completion of the transaction, the insider now owns 24,116,498 shares of the company’s stock, valued at $37,862,901.86. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Steve Hoffman also recently made the following trade(s):

  • On Wednesday, May 26th, Steve Hoffman sold 41,250 shares of Tyme Technologies stock. The shares were sold at an average price of $1.38, for a total transaction of $56,925.00.
  • On Tuesday, May 11th, Steve Hoffman sold 41,250 shares of Tyme Technologies stock. The shares were sold at an average price of $1.20, for a total transaction of $49,500.00.
  • On Wednesday, April 28th, Steve Hoffman sold 83,500 shares of Tyme Technologies stock. The shares were sold at an average price of $1.57, for a total transaction of $131,095.00.
  • On Tuesday, April 13th, Steve Hoffman sold 41,750 shares of Tyme Technologies stock. The shares were sold at an average price of $1.51, for a total transaction of $63,042.50.
  • On Thursday, March 25th, Steve Hoffman sold 41,750 shares of Tyme Technologies stock. The shares were sold at an average price of $1.79, for a total transaction of $74,732.50.

Shares of NASDAQ:TYME opened at $1.59 on Friday. The company has a market capitalization of $207.38 million, a P/E ratio of -7.57 and a beta of 1.04. The company’s 50-day moving average price is $1.48. Tyme Technologies, Inc. has a 12 month low of $0.85 and a 12 month high of $4.99.

Several hedge funds and other institutional investors have recently made changes to their positions in TYME. BlackRock Inc. increased its position in shares of Tyme Technologies by 30.2% during the first quarter. BlackRock Inc. now owns 5,798,366 shares of the company’s stock valued at $10,320,000 after buying an additional 1,344,181 shares during the period. Geode Capital Management LLC grew its holdings in Tyme Technologies by 44.3% in the first quarter. Geode Capital Management LLC now owns 1,284,630 shares of the company’s stock worth $2,286,000 after purchasing an additional 394,202 shares during the period. Morgan Stanley grew its holdings in Tyme Technologies by 382.3% in the first quarter. Morgan Stanley now owns 276,924 shares of the company’s stock worth $493,000 after purchasing an additional 219,507 shares during the period. Virtu Financial LLC grew its holdings in Tyme Technologies by 933.6% in the first quarter. Virtu Financial LLC now owns 201,675 shares of the company’s stock worth $359,000 after purchasing an additional 182,163 shares during the period. Finally, Millennium Management LLC purchased a new stake in Tyme Technologies in the first quarter worth about $289,000. Institutional investors own 15.30% of the company’s stock.

About Tyme Technologies

Tyme Technologies, Inc, a clinical-stage biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead candidate is the SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, lung, breast, prostate, sarcoma, and lymphoma.

Featured Article: Momentum Investing

Insider Buying and Selling by Quarter for Tyme Technologies (NASDAQ:TYME)

Receive News & Ratings for Tyme Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tyme Technologies and related companies with MarketBeat.com's FREE daily email newsletter.